Related Experiment Videos
Epilepsy and psychiatric disturbance. A cross-sectional study
E Fiordelli1, E Beghi, G Bogliun
1Centro Regionale per l'Epilessia and Clinica Neurologica, Ospedale San Gerardo, Monza, Milan, Italy.
Summary
Patients with cryptogenic epilepsy and normal intelligence show similar rates of psychiatric disorders, primarily anxiety and depression, compared to controls. This suggests no elevated risk for mental health issues in this patient group.
Area of Science:
- Neurology
- Psychiatry
- Clinical Psychology
Background:
- Cryptogenic epilepsy affects individuals with normal cognitive function.
- Understanding the psychiatric comorbidity in epilepsy is crucial for comprehensive patient care.
- Previous research has indicated potential links between epilepsy and mental health disorders.
Purpose of the Study:
- To investigate the prevalence of psychiatric disorders in patients with cryptogenic epilepsy and normal intelligence.
- To compare psychiatric diagnoses in epilepsy patients with age- and sex-matched controls.
- To determine if cryptogenic epilepsy with normal cognition poses an increased risk for psychiatric disturbances.
Main Methods:
- A psychiatric interview using the Clinical Interview Schedule was conducted.
- One hundred patients with cryptogenic epilepsy and normal intelligence were assessed.
- One hundred age- and sex-matched controls without neurological conditions were included for comparison.
Main Results:
- Psychiatric disorders were identified in 19 patients and 15 controls.
- Anxiety and depression were the most common diagnoses in both groups.
- Personality disorders were infrequently observed in the epilepsy cohort.
Conclusions:
- Patients with cryptogenic epilepsy and normal neuropsychological abilities do not exhibit a higher risk of psychiatric disturbance compared to the general population.
- The findings challenge the assumption of increased psychiatric vulnerability solely based on epilepsy diagnosis in cognitively unimpaired individuals.
- Routine psychiatric screening may be warranted for both epilepsy patients and controls due to similar comorbidity rates.